Cargando…

Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study

BACKGROUND: This study aimed to investigate the impact of depression and anxiety scores on disease activity at 1-year follow-up in people with Rheumatoid Arthritis (RA). METHODS: The Hospital Anxiety Depression Scale (HADS) was used to measure depression and anxiety in a cross-section of RA patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Matcham, Faith, Ali, Sheila, Irving, Katherine, Hotopf, Matthew, Chalder, Trudie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827220/
https://www.ncbi.nlm.nih.gov/pubmed/27068100
http://dx.doi.org/10.1186/s12891-016-1011-1
_version_ 1782426441938370560
author Matcham, Faith
Ali, Sheila
Irving, Katherine
Hotopf, Matthew
Chalder, Trudie
author_facet Matcham, Faith
Ali, Sheila
Irving, Katherine
Hotopf, Matthew
Chalder, Trudie
author_sort Matcham, Faith
collection PubMed
description BACKGROUND: This study aimed to investigate the impact of depression and anxiety scores on disease activity at 1-year follow-up in people with Rheumatoid Arthritis (RA). METHODS: The Hospital Anxiety Depression Scale (HADS) was used to measure depression and anxiety in a cross-section of RA patients. The primary outcome of interest was disease activity (DAS28), measured one-year after baseline assessment. Secondary outcomes were: tender joint count, swollen joint count, erythrocyte sedimentation rate and patient global assessment, also measured one-year after baseline assessment. We also examined the impact of baseline depression and anxiety on odds of reaching clinical remission at 1-year follow-up. RESULTS: In total, 56 RA patients were eligible for inclusion in this analysis. Before adjusting for key demographic and disease variables, increased baseline depression and anxiety were associated with increased disease activity at one-year follow-up, although this was not sustained after adjusting for baseline disease activity. There was a strong association between depression and anxiety and the subjective components of the DAS28 at 12-month follow-up: tender joint count and patient global assessment. After adjusting for age, gender, disease duration and baseline tender joint count and patient global assessment respectively, higher levels of depression and anxiety at baseline were associated with increased tender joint count and patient global assessment scores at 1-year follow-up. CONCLUSIONS: Symptoms of depression and anxiety have implications for disease activity, as measured via the DAS28, primarily due to their influence on tender joints and patient global assessment. These findings have implications for treatment decision-making as inflated DAS28 despite well controlled inflammatory disease markers may indicate significant psychological morbidity and related non-inflammatory pain, rather than true disease activity.
format Online
Article
Text
id pubmed-4827220
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48272202016-04-12 Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study Matcham, Faith Ali, Sheila Irving, Katherine Hotopf, Matthew Chalder, Trudie BMC Musculoskelet Disord Research Article BACKGROUND: This study aimed to investigate the impact of depression and anxiety scores on disease activity at 1-year follow-up in people with Rheumatoid Arthritis (RA). METHODS: The Hospital Anxiety Depression Scale (HADS) was used to measure depression and anxiety in a cross-section of RA patients. The primary outcome of interest was disease activity (DAS28), measured one-year after baseline assessment. Secondary outcomes were: tender joint count, swollen joint count, erythrocyte sedimentation rate and patient global assessment, also measured one-year after baseline assessment. We also examined the impact of baseline depression and anxiety on odds of reaching clinical remission at 1-year follow-up. RESULTS: In total, 56 RA patients were eligible for inclusion in this analysis. Before adjusting for key demographic and disease variables, increased baseline depression and anxiety were associated with increased disease activity at one-year follow-up, although this was not sustained after adjusting for baseline disease activity. There was a strong association between depression and anxiety and the subjective components of the DAS28 at 12-month follow-up: tender joint count and patient global assessment. After adjusting for age, gender, disease duration and baseline tender joint count and patient global assessment respectively, higher levels of depression and anxiety at baseline were associated with increased tender joint count and patient global assessment scores at 1-year follow-up. CONCLUSIONS: Symptoms of depression and anxiety have implications for disease activity, as measured via the DAS28, primarily due to their influence on tender joints and patient global assessment. These findings have implications for treatment decision-making as inflated DAS28 despite well controlled inflammatory disease markers may indicate significant psychological morbidity and related non-inflammatory pain, rather than true disease activity. BioMed Central 2016-04-11 /pmc/articles/PMC4827220/ /pubmed/27068100 http://dx.doi.org/10.1186/s12891-016-1011-1 Text en © Matcham et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Matcham, Faith
Ali, Sheila
Irving, Katherine
Hotopf, Matthew
Chalder, Trudie
Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study
title Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study
title_full Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study
title_fullStr Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study
title_full_unstemmed Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study
title_short Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study
title_sort are depression and anxiety associated with disease activity in rheumatoid arthritis? a prospective study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827220/
https://www.ncbi.nlm.nih.gov/pubmed/27068100
http://dx.doi.org/10.1186/s12891-016-1011-1
work_keys_str_mv AT matchamfaith aredepressionandanxietyassociatedwithdiseaseactivityinrheumatoidarthritisaprospectivestudy
AT alisheila aredepressionandanxietyassociatedwithdiseaseactivityinrheumatoidarthritisaprospectivestudy
AT irvingkatherine aredepressionandanxietyassociatedwithdiseaseactivityinrheumatoidarthritisaprospectivestudy
AT hotopfmatthew aredepressionandanxietyassociatedwithdiseaseactivityinrheumatoidarthritisaprospectivestudy
AT chaldertrudie aredepressionandanxietyassociatedwithdiseaseactivityinrheumatoidarthritisaprospectivestudy